These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20714166

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
    Evenepoel P, Selgas R, Caputo F, Foggensteiner L, Heaf JG, Ortiz A, Kelly A, Chasan-Taber S, Duggal A, Fan S.
    Nephrol Dial Transplant; 2009 Jan; 24(1):278-85. PubMed ID: 18820280
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
    Itoh K, Tanaka M, Hashiguchi J, Funakoshi S, Nakano H, Kubo H, Kono T, Uchino J, Masaki K, Date T, Shigematsu T, Research Group for Future Hemodialysis.
    Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis.
    Goldsmith DR, Scott LJ, Cvetković RS, Plosker GL.
    Drugs; 2008 Apr; 68(1):85-104. PubMed ID: 18081374
    [Abstract] [Full Text] [Related]

  • 8. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.
    Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M, Emoto M, Ishimura E, Nakatani T, Miki T, Inaba M.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S76-9. PubMed ID: 12612958
    [Abstract] [Full Text] [Related]

  • 9. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
    Liu YL, Lin HH, Yu CC, Kuo HL, Yang YF, Chou CY, Lin PW, Liu JH, Liao PY, Huang CC.
    Ren Fail; 2006 Mar; 28(8):701-7. PubMed ID: 17162430
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Advanced atherosclerosis in predialysis patients with chronic renal failure.
    Shoji T, Emoto M, Tabata T, Kimoto E, Shinohara K, Maekawa K, Kawagishi T, Tahara H, Ishimura E, Nishizawa Y.
    Kidney Int; 2002 Jun; 61(6):2187-92. PubMed ID: 12028459
    [Abstract] [Full Text] [Related]

  • 12. Predictive value of carotid intima media thickness in hemodialysis patients.
    Ekart R, Hojs R, Hojs-Fabjan T, Balon BP.
    Artif Organs; 2005 Aug; 29(8):615-9. PubMed ID: 16048477
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA, Shepler BM.
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [Abstract] [Full Text] [Related]

  • 14. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis.
    Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A.
    Int Urol Nephrol; 2008 Jul; 40(4):1075-82. PubMed ID: 18568412
    [Abstract] [Full Text] [Related]

  • 15. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
    Takei T, Otsubo S, Uchida K, Matsugami K, Mimuro T, Kabaya T, Akiba T, Nitta K.
    Nephron Clin Pract; 2008 Jul; 108(4):c278-83. PubMed ID: 18434749
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan.
    Koiwa F, Onoda N, Kato H, Tokumoto A, Okada T, Fukagawa M, Shigematsu T, ROD 21 Clinical Research Group.
    Ther Apher Dial; 2005 Aug; 9(4):340-6. PubMed ID: 16076379
    [Abstract] [Full Text] [Related]

  • 19. Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients.
    Ishimura E, Taniwaki H, Tabata T, Tsujimoto Y, Jono S, Emoto M, Shoji T, Inaba M, Inoue T, Nishizawa Y.
    Am J Kidney Dis; 2005 May; 45(5):859-65. PubMed ID: 15861351
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.